乐赚网
INDEX
ABOUT JUNSHI
THERAPEUTIC AREAS
PRESS RELEASES
CAREERS
INVESTORS
CONTACT
Entrance
中文簡體
中文繁體
EN
Menu
INDEX
ABOUT JUNSHI
THERAPEUTIC AREAS
PRESS RELEASES
CAREERS
INVESTORS
CONTACT
中文簡體
中文繁體
EN
PRESS RELEASES
Junshi Biosciences and Coherus Announce Toripalimab Granted ODD for SCLC in the US
04-13
2022
Junshi Biosciences and Coherus Present Results of Phase 3 Study of Toripalimab in NPC at 2022 AACR
04-08
2022
Junshi Biosciences Announces FDA Approval of IND for Anti-CD112R Monoclonal Antibody
04-03
2022
Junshi Biosciences Announces First Patient Dosed in China in Phase III Clinical Trial of VV116
03-16
2022
More
Back
List
//
趣投网官网
彩神x
thehappycookerblog.comphppop.netcuddlepatchkids.com
